Current studies often focus on isolated aspects of the disease, which hampers the integration of findings into a cohesive understanding of SONFH pathogenesis
Jakkampudi A, Jangala R, Reddy BR, Mitnala S, Nageshwar Reddy D, Talukdar R
Zepbound is also FDA approved for treating moderate-to-severe obstructive sleep apnea in adults with obesity
These predispositions do not predict your exact response to semaglutide or tirzepatide, but they may help provide context for provider decision-making about dose escalation, medication selection, or potential side-effect risk
[1] [2] It is important to recognise that any medication can potentially cause skin reactions in susceptible individuals
Some individuals may experience mild discomfort, irritation, or an urge to defecate after inserting a suppository